19.22Open19.22Pre Close0 Volume0 Open Interest73.00Strike Price0.00Turnover0.00%IV13.81%PremiumMay 2, 2025Expiry Date10.60Intrinsic Value100Multiplier2DDays to Expiry8.62Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma6.06Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Sarepta Therapeutics Stock Discussion
Sarepta Expands Rare Disease Pipeline: FDA Green Light for New LGMD Trial
The Nasdaq gained 316.1 points (1.4%) to 17,750.79, the S&P 500 added 60.63 ticks (1.1%) to 5,675.29 and the DJIA rose 383.32 points (0.9%) to 41,964.63 after the Fed...
The $Nasdaq Composite Index (.IXIC.US)$ shed 304.54 points (1.7%) to a 17,504.12 close, while the $S&P 500 Index (.SPX.US)$ gave up 60.45 ticks (1.1%) to 5,614.66 and the $Dow Jones Industrial Average (.DJI.US)$ lost 260....
No comment yet